Maya Balakrishnan, MD
Gastroenterology · Houston, TXNPI 1295911584
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intercept Pharmaceuticals, Inc. at 42.9% of the total.
Across 27 payments — averaging $393.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intercept Pharmaceuticals, Inc.$5K
- Madrigal Pharmaceuticals$3K
- Novo Nordisk$3K
- Gilead$51
- Albireo Pharma, Inc.$44
- Takeda Pharmaceuticals U.S.A., Inc.$29
- plus $61 from 3 others
Across 354 payments — averaging $2150.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharmaceuticals, Inc.$574K
- Intercept Pharma Europe Ltd.$104K
- Novo Nordisk AS$58K
- Gilead$14K
- Madrigal Pharmaceuticals$6K
- Boehringer Ingelheim International GmbH$5K
What the payments were for
- Consulting fees$5,53352%
- Speaking & faculty fees$3,60034%
- Travel & lodging$6696%
- Food & beverage$8118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intercept Pharmaceuticals, Inc. | 9 | $4,551 |
| Madrigal Pharmaceuticals | 9 | $3,119 |
| Novo Nordisk | 2 | $2,757 |
| Gilead | 2 | $51 |
| Albireo Pharma, Inc. | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZDIFFRA$3,019
How this compares
$10,613 in reported general payments places this provider in the 80th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Houston
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Brooks CashHouston$867K
- Mohamed OthmanHouston$777K
- Isaac RaijmanHouston$565K
- Kalpesh PatelHouston$382K
- Victor Ankoma-SeyHouston$340K
- John VierlingHouston$270K
- George TriadafilopoulosHouston$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.